Abcellera Biologics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Abcellera Biologics Stock Summary

Abcellera Biologics competes with Hepion Pharmaceuticals, Krystal Biotech, CureVac NV, Vir Biotechnology, and PTC Therapeutics. AbCellera Biologics Inc. develops antibody discovery platform. The company was incorporated in 2012 and is headquartered in Vancouver, Canada. Abcellera Biologics is traded on NASDAQ Exchange in the United States.

Abcellera Biologics Key Financial Ratios

Abcellera Biologics Key Balance Sheet Accounts

Abcellera Biologics Key Cash Accounts

Abcellera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abcellera Biologics's current stock value. Our valuation model uses many indicators to compare Abcellera Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abcellera Biologics competition to find correlations between indicators driving Abcellera Biologics's intrinsic value. More Info.Abcellera Biologics is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . At this time, Abcellera Biologics' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Abcellera Biologics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Abcellera Biologics Systematic Risk

Today, most investors in Abcellera Biologics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abcellera Biologics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Abcellera Biologics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Abcellera Biologics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abcellera Biologics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abcellera Biologics based on widely used predictive technical indicators. In general, we focus on analyzing Abcellera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abcellera Biologics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.